Sleep Apnea Pill Efficacy Confirmed in Second Phase 3 Trial
"With two large phase 3 studies now demonstrating a consistent and significant efficacy profile for AD109, we are closer to delivering the first oral pharmacotherapy for over 80 million US adults with OSA."
The post Sleep Apnea Pill Efficacy Confirmed in Second Phase 3 Trial appeared first on Healthcare Communications Network.